Overall, our data suggest that, within the TIGIT/CD155 axis, TIGIT expression is associated with MSI status at the protein level in CRC, reinforcing the concept that MSI-associated epigenetic and immunological alterations preferentially favor the derepression and induction of immune checkpoint receptors such as TIGIT. This evidence concerns the gene PVR and colorectal carcinoma.